1 follower
Acumen is forging a new path towards safe and effective treatments for Alzheimer’s disease and other neurodegenerative diseases through our focus on the biology of toxic amyloid-beta oligomers.
Daniel O’Connell
Umoja Biopharma
3 followers
Madrigal Pharmaceuticals
2 followers
ADARx Pharmaceuticals
3 followers
Bristol-Myers Squibb
207 followers
Walgreens Boots Alliance
111 followers
SpyGlass Pharma, Inc.
1 follower
VIRIXENE
121 followers
Syneos Health
23 followers
Alnylam Pharmaceuticals
23 followers
Organon
17 followers
NYU Langone Health
16 followers
Explore companies